Covid-19 vaccine in the U.S. will be transparent to the public, with any clearance by the agency driven by data alone.In an interview on Sunday, Commissioner Stephen Hahn responded to questions about the different ways the FDA could clear a vaccine for use: either under an emergency authorization, likely based on more limited data and for use in a narrow group, or a broader approval that could lead to wider use.“We’ve said all along we’re not going to pre-judge what mechanism we’re going to use to authorize or approve a vaccine," Hahn told Bloomberg News by phone. “We’re going to let the data dictate that.
The data will dictate what kind of decision is made on the vaccine."No decision on that has been made, because the agency hasn’t seen.